Dominant negative TGF-β receptor II (dnTGF-βRII) mice spontaneously develop an autoimmune cholangitis resembling human primary biliary cirrhosis (PBC). Interestingly, the dominant negative TGF-β receptor is expressed by both CD4 + and CD8 + T cells and leads to greatly reduced (but not absent) TGF-β signaling resulting in T cell intrinsic cell mediated autoimmunity. However, the mechanisms of the T cell dysregulation remain unclear. Recently it has been shown that TGF-β signaling is intimately involved with miRNA biogenesis and control. Herein we show that lack of T cell TGF-β signaling leads to down regulation of T cell miRNAs but upregulation of the key inflammatory miRNA 21. Furthermore, the expression of miR-21 from hepatic effector CD8 + T cells is significantly higher than in the same subsets isolated from spleen and mesenteric lymph nodes of the dnTGF-βRII mice. Previous studies indicate that miR-21 increases the synthesis of IFN-γ and IL-17A by T cells and suppresses apoptosis via programmed cell death protein 4 (PDCD4). Data presented herein demonstrate that transfecting w.t. B6 T cell subsets with miR-21 resulted in upregulation of the inflammatory cytokines TNF-α and IFN-γ, thus partly replicating the dnTGF-βRII T cell phenotype. In conclusion, these data suggest miR-21 plays a critical role in the production of pro-inflammatory cytokines in dnTGFβRII mice, which could be a contributing factor for the development of the organ-specific autoimmune cholangitis and colitis in this murine model of human PBC.
Introduction
Mice transgenic for directed expression of a dominant negative form of transforming growth factor beta receptor type II (dnTGFβRII), under the control of the CD4 promoter lacking the CD8 silencer, spontaneously develop an autoimmune biliary ductular disease with similarity to human primary biliary cirrhosis (PBC). In addition, dnTGFβRII mice spontaneously develop colitis similar to human inflammatory bowel disease (IBD) [1] [2] [3] [4] [5] . The utilization of adoptive transfer experiments have demonstrated that CD8 + T cells play a critical role in the autoimmune cholangitis, while CD4 + T cells are involved in colitis [2] .
MicroRNAs (miRNAs) are small noncoding RNAs that control the translation of mRNAs by promoting the degradation of target mRNAs or preventing their translation [6] [7] [8] . Given the emerging roles of miRNAs in modulating both innate and adoptive immune responses, it is likely that any dysregulation of miRNA expression may contribute to the pathogenesis of autoimmune diseases and chronic inflammation [9] . Dysregulated miRNA expression has been associated with autoimmunity, specifically rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) [10] [11] [12] . TGF-β receptor mediated signaling has been shown to directly regulate miRNA biogenesis by at least three mechanisms: 1) direct gene transcription of miRNA genes, 2) direct binding of TGFβ receptor induced SMAD proteins to specific miRNAs, and 3) stabilization of miRNA processing machinery [13] [14] [15] . The net effect of TGF-β signaling is to upregulate miRNA biogenesis. Our goal was to investigate whether abrogation of TGF-β signaling in mouse CD4 + and CD8 + T cells affects miRNA expression and involvement in the pathogenesis of cholangitis. We demonstrate herein that, as expected, the overall effect of loss of TGF-β signaling resulted in the downregulation of many species of miRNA in T cells. Surprisingly, however, loss of TGF-β signaling resulted in the upregulation of several important miRNAs, including miR-21. The level of miR-21 was elevated in both CD4 + and CD8 + T cells compared with control mice. Furthermore, transfection of miR-21 in B6 T cells resulted in enhanced secretion of IFN-γ and TNF-α, recapitulating the dnTGFβRII T cell phenotype.
Materials and Methods

Animals
The dnTGFβRII colony on a C57BL/6 background (B6.Cg-Tg(Cd4-TGFBR2)16Flv/J) was maintained at the University of California at Davis animal facility [16] . B6 mice were purchased from The Jackson Laboratory. All mice were fed sterile rodent Helicobacter Medicated Dosing System (three-drug combination) diets (Bio-Serv, Frenchtown, NJ) and maintained in individually ventilated cages under specific pathogen-free conditions. Sulfatrim (Hi-tech Pharmacal, Amityville, NY) was delivered through drinking water. At 9 weeks of age, animals were sacrificed to collect sera, spleen, liver, and colon tissues. In addition, at 2 weeks of age, animals were sacrificed to collect thymus and spleen. The liver and colon from sacrificed mice were fixed in 4% paraformaldehyde, embedded in paraffin, cut into 4 µm sections, deparaffinized, stained with hematoxylin and eosin (H&E), and evaluated using light microscopy [17] . All experimental protocols were approved by the University of California Animal Care and Use Committee.
Flow Cytometry
Mononuclear cells (MNCs) were isolated from liver, spleen, and mesenteric lymph node (mLN) [18, 19] . The cells were re-suspended in staining buffer (0.2% BSA, 0.04% EDTA and 0.05% sodium azide in PBS), divided into 25µl aliquots, and incubated with anti-mouse FcR blocking reagent (eBioscience) for 15 minutes at 4°C. Cells were washed and stained for 30 minutes at 4°C with a combination of fluorochrome conjugated mAb against the cell surface markers CD4, CD8α, NK1.1 (Biolegend, San Diego, CA), and TCR-β (eBioscience, San Diego, CA). To define naive versus effector T cell subpopulations, antibodies against CD62L and CD44 were used as described [1, 20, 21] . IgG isotype antibodies with matching conjugates were used in parallel as negative controls. The stained cells were washed with PBS containing 0.2% BSA before acquiring data on a FACScan flow cytometer (BD Immunocytometry Systems, San Jose, CA) upgraded for detection of 5 colors by Cytek Development (Fremont, CA). The data were analyzed using Cellquest PRO software.
Isolation of cell and total RNA including small RNA-A MoFlo cell sorter (Beckman Coulter, Brea, CA) was used to isolate enriched populations of CD44 − CD62L + naïve or CD44 + CD62L − effector CD4 and CD8 T cells from liver, spleen, and mLN, and to isolate enriched populations of CD4 and CD8 T cells from thymic tissues of mice. CD4 (L3T4) MicroBeads and CD8a (Ly-2) MicroBeads (Miltenyi Biotec, Auburn, CA) were used to enrich CD4 and CD8 T cells from spleen, liver and colon MNCs, respectively. Purity of isolated cells was re-analyzed on an aliquot of the enriched cells by flow cytometry. Post-purification purity of cells was >95%. For total RNA isolation (including small RNA), the isolated cells were washed three times with PBS. RNA extraction was performed using miRNeasy Mini kit (Qiagen, Valencia, CA) and chloroform (Sigma, St. Louis, MO).
miRNA PCR arrays-The microRNA Ready-to-Use PCR, Mouse & Rat panel I, V2.M (EXIQON) containing 376 mouse and rat miRNAs was utilized to obtain miRNA profiles.. Threshold cycle (Ct) number of each miRNA was acquired after the plates were run on a ViiA™ 7 Real-Time PCR System (Life Technologies, Carlsbad, CA). The results were analyzed as follows: we first defined very low expressing or non-expressing Ct (from either B6 or dnTGFbRII) as greater than or equal to 37 cycles and any miRNA with Ct greater than 37 in both strains was removed these from the dataset. In each strain, the remaining miRNAs were normalized to the global mean of miRNAs with Cts no greater than 35. Global mean normalization is preferred in screening studies where the dataset has a high number of expressed miRNAs (eg. >100) without assumptions about how many and/or which miRNAs are regulated. However, miRNAs expressed close to the cut-off tend to have greater technical variation than those expressed at lower Ct values, therefore only miRNAs with Cts less than or equal to 35 were used to calculate the global mean in our analysis. Cells from the B6 mice were used as a reference for each normalized miRNA. Fold changes (FC) of miRNA expression in dnTGFbRII compared to B6 splenic CD4 + and CD8 + T cells were calculated. Finally, FC values were converted to a log scale to obtain a normal distribution and plotted for each miRNA with Ct no greater than 37.
Biological pathway analysis of miRNA expression data-miRNAs with at least 2fold increase or decrease in dnTGFbRII CD4 or CD8 T cells compared to B6 counterparts were inputted to the multiple microRNAs Analysis function of the web-based DIANA mirPath software (http://diana.cslab.ece.ntua.gr/pathways/index_multiple.php). TargetScan5 was selected for miRNA target prediction and the enrichment analysis of target genes was performed by the mirPath software by comparing the genes to all known pathways retrieved from KEGG (Kyoto Encyclopedia of Genes and Genomes, www.genome.jp/kegg/). A ranking score was calculated on the basis of the number of predicted target genes of all the miRNAs in the list as well as the position of these genes within the pathway. Higher scores mean a higher possibility of control by the selected miRNA. Pathways in which miRNAs are upregulated (or downregulated) in CD4 T cells are compared to those in which miRNAs are upregulated (or downregulated) in CD8 T cells to detect the pathway patterns controlled by these miRNAs in the two T cell populations.
Quantitative real time PCR for miRNAs-PCR primers for mmu-miR-21 and SNORD66 were purchased from Qiagen. miRNA was converted to cDNA using RT 2 miRNA First Strand kit (Qiagen). Real time PCR reactions were performed according to the manufacturer's instructions, using a ViiA™ 7 Real-Time PCR System (Life Technologies). The measured levels of miR-21 were normalized to that of SNORD66 to obtain the relative levels of miR-21 in specific cell populations.
Overexpression of miR-21miRNA-Purified CD4 + and CD8 + T cells from spleens of the B6 mice were transfected with 25nM of miR-21 mimic (Qiagen) [22] , or Allstar negative control siRNA (Qiagen) [23] , using TransIT-TKO Transfection Reagent (Mirus, Madison, WI), following the manufacturer's instructions. The transfected cells were cultured overnight in RPMI 1640 medium with 10% FBS at 37°C in 5% CO 2 , then stimulated with 0.5µg/ml of anti-CD3/CD28 antibodies (Biolegend) for 48 hours. The culture supernatant was collected for cytokine assay, while cell pellets were frozen at −80°C for miRNA analysis.
Cytokine Analysis
Total protein was extracted from 30 mg of frozen liver or colon tissues by homogenization in T-Per® tissue protein extraction buffer (Thermo, Rockford, IL) containing a protease inhibitor cocktail (Roche, Indianapolis, IN). The homogenized tissue suspension was centrifuged at 12,000 g for 20 minutes at 4°C and the supernatant was stored at −80°C until use. The total protein concentration of each sample was measured by a BCA protein assay kit (Thermo Fisher Scientific, Waltham, MA). Levels of IL-17A, TNF-α, IL-6, and IFN-γ in sera, tissue lysates or culture media were measured by a mouse Th1/Th2/Th17 cytokine CBA kit (BD Biosciences).
Statistical analysis-Groups were compared using the non-parametric Mann-Whitney Utest or Student's t-test as appropriate. miRNA array data were analyzed using the SABiosciences web analysis portal.
Results
Cholangitis and Colitis in dnTGFβRII mice
Cholangitis and colitis were observed at 9 weeks of age ( Fig. 1A) . The levels of IFN-γ, IL-17A, TNF-α and IL-6 in serum, liver, and colon were significantly increased in the dnTGFβRII mice compared to age-matched B6 mice (Fig. 1B) . The number of intrahepatic MNCs, CD4 + T cells, and CD8 + T cells were significantly higher in dnTGFβRII mice than that of B6 mice (Fig. 1C ). In addition, the total number of MNCs in mLNs, which correlates with colitis severity [24, 25] , was also significantly increased in dnTGFβRII mice compared to age-matched B6 mice ( Fig. 1D ).
miRNAs are predominantly down-regulated in dnTGFbRII splenic CD4 + and CD8 + T cells but miR-21 is upregulated
As shown in Fig. 2 , the majority of miRNA are downregulated in dnTGFβRII CD4 + and CD8 + T cells, as expected given the biological role of TGF-β in miRNA biogenesis [13] [14] [15] . Thus, CD8 + T cells show a striking down regulation of miRNA with 142/285 (50%) miRNAs showing a more than 2-fold decrease in dnTGFβRII CD8 + T cells compared to B6 CD8 + T cells, and only 19/285 (7%) miRNAs with more than 2-fold increase in dnTGFβRII CD8 T cells compared to B6 CD8 + T cells. A similar pattern is seen in CD4 + T cells with 86/320 (27%) miRNA showing more than a 2-fold decrease in dnTGFβRII CD4 + T cells, and 28/320 (9%) miRNAs showing more than 2-fold increase in dnTGFβRII CD4 + T cells compared to B6 CD4 + T cells. The smaller subset (~7-9%) of upregulated miRNAs was somewhat surprising given the role of TGF-β signaling in general to upregulate miRNA. We analyzed miRNA expression patterns of CD4 and CD8 T cells to see if the expression patterns (up or down) correlated between the two cell subsets. As shown in Figure 2b , the upregulated or downregulated miRNA's differed substantially between CD4 and CD8 T cell subsets, suggesting differential miRNA programming in response to TGFβ in these cell subsets. However, as shown in Figure 2c , we performed a pathway analysis of the biological pathways controlled by these miRNAs (either down or upregulated). Table one shows the top 20 pathways controlled by the miRNAs in each of the four cell subsets. Strikingly, the pathways controlled were largely conserved, with a majority of biological pathways overlapping in both the down-and up-regulated miRs from CD4 and CD8 cells (Fig 2c) .
The most surprising result of the global miRNA analysis was the finding of an upregulation of a small number of miRNA, since TGFβ signaling is known primarily to upregulate miRNA and therefore loss of TGFβ signaling should downregulate miRNA (as it did for most miRNA). Thus, the reason why only a few miRNA were upregulated remains unclear. The miR-21 was of the greatest interest, since it has been published that TGF-β signaling upregulates miR21. Upregulation of miR-21 was also of great interest as miR-21 upregulation has been strongly correlated with the development of a variety of autoimmune diseases including T cell-derived psoriatic skin inflammation [26] , SLE [27] and autoimmune type 1 diabetes (T1D) [28] . To understand how miR21 could be upregulated in the absence of TGF-β signaling, subsequent studies were focused on the analysis of the role of miR-21.
Levels of miR-21expression in T cells of dnTGFβRII mice
To confirm the pattern of expression, we repeated microRNA screening using an individual miRNA PCR assay to directly compare the relative levels of miR-21 expression in total CD4 + and CD8 + T cells isolated from the spleen, liver and colon from 9-week old dnTGFβRII mice and age matched B6 mice. In spleen, liver, and colon, the relative levels of miR-21 were all significantly higher in dnTGFβRII than the B6 mice ( Figure 3 ). Next we compared the relative miR-21 levels in purified naïve and effector CD4 + and CD8 + T cells between the two mouse strains. As shown in Fig. 4A , both effector CD4 + and CD8 + T cells expressed higher miR-21 than naïve cells. Again, miR-21 was expressed significantly higher in dnTGFβRII effector T cells compared to B6 effector T cells in all tissues that we tested. Of note, the relative miR-21 level of effector CD8 + T cells in liver was significantly higher than the spleen and mLNs (Fig. 4B) . These PCR results therefore confirmed our paradoxical result that dnTGFβRII T cells show upregulated miR21 in the face of global miRNA downregulation in the previous PCR array.
miR-21is increased at both early and late time points in dnTGFβRII disease
To begin to assess whether the elevated miR-21 level in the dnTGFβRII mice was a secondary effect of overall autoimmune disease in the dnTGFβRII mice, or an intrinsic characteristic unique to the abrogation of TGF-β signaling, we measured the miR-21 levels at the age of 2-weeks (before the onset of symptoms or significant pathology in the dnTGFβRII mice). As shown in Fig. 5A , the relative levels of miR-21 in both CD4 + and CD8 + T cells isolated from the thymus were significantly higher in the 2-week old dnTGFβRII mice than the 2-week old B6 mice. Next we examined if there is any difference in miR-21 levels before (2-week old mice) and after (9-week old mice) disease onset. The relative levels of miR-21 in splenic CD4 + and CD8 + T cells increased in both dnTGFβRII mice and B6 mice at 9 weeks compared to 2 weeks old. Further, at both ages, miR-21 levels were significantly higher in the dnTGFβRII mice than that of B6 mice (Fig. 5B) . These results suggest that the elevated miR-21 levels in T cells of the dnTGFβRII mice start at an early age but are enhanced by the immune activation of T cells associated with the progression of disease.
Transfection of miR-21 into normal B6 T cells enhanced production of pro-inflammatory cytokines
To investigate the effects of elevated miR-21 on T cell function, we isolated CD4 + and CD8 + T cells from spleen of B6 mice and transfected them with a miR-21 mimic followed by stimulation with anti-CD3/CD28 mAb. After transfection, the cellular level of miR-21 expression was significantly increased in both CD4 + and CD8 + T cells transfected with miR-21 mimics as compared to that of control group (Fig. 6A) . We next measured the proinflammatory cytokine production by these transfected cells. As shown in Fig. 6B , the amounts of IFN-γ and TNF-α in the supernatant of cells were significantly increased in miR-21 transfected group as compared with that of control group.
Discussion
Since it is well established that TGF-β signaling upregulates miRNA expression via multiple mechanisms [13] [14] [15] , we investigated the levels of miRNA in dnTGFβRII with the hypothesis that we would see global miRNA downregulation which could contribute to the intrinsic pathogenicity of T cells from the dnTGFβRII mice. In fact, we did find overall miRNA down regulation in CD4 + and CD8 + T cells from the of dnTGFβRII mice (Fig. 2) . However, somewhat surprisingly, we also found an up-regulation of a small subset of miRNAs (Fig 2) . Most interesting to us was the up-regulation of miR-21 in both CD4 + and CD8 + subsets. A fascinating parallel to this result is found in cancer biology, where it has been shown that while most miRNAs are downregulated, miR-21 is up-regulated [15] . Similar up-regulation of miR-21 has been found in other autoimmune conditions. Human IBD patients have colonic overexpression of miR-21 [29, 30] similar to the colonic inflammation in IL-10 −/− mice, an animal model of Th1-mediated IBD which is also accompanied by the up-regulation of miR-21 [31] . Since the elevated level of miR-21 is observed before the onset of clinical pathology, the miR-21 overexpression is likely to be a consequence of disrupted TGF-β signaling which is further increased by subsequent inflammation. We also demonstrate by in vitro transfection experiments that the experimental overexpression of miR-21 in the T cells derived from control mice results in enhanced production of pro-inflammatory cytokines.
Adoptive transfer of CD8 + T cells from dnTGFβRII into B6/Rag1 −/− mice leads to liver histopathology. In contrast, adoptive transfer of CD4 + T cells predominantly induces IBD in recipient mice [2] . It is of interest to note that whereas there is a global down regulation of miRNA in all sources of CD8+ T cells from the dnTGFβRII mice, there was a strikingly higher level of miR-21 in intrahepatic effector CD8 + T cells as compared to that of spleen and mLN (Fig. 5B) . These findings prompted us to perform miR-21 transfection experiments in efforts to specifically study the role of miR-21 expression. As shown above, the overexpression of miR-21 in normal mouse T cells resulted in an increased production of the pro-inflammatory cytokines IFN-γ and TNF-α upon TCR stimulation. These findings indicate that miR-21 might be a target of clinical treatment for inflammation in chronic autoimmune disease. IFN-γ secretion was higher in transfected CD8 + T cells than in CD4 + T cells; TNF-α secretion was higher in transfected CD4 + T cells than in CD8 + T cells (Fig.  6B) . These findings indicate a differential role of the two cytokines in the pathogenesis of the two major clinical manifestations of disease.
The miR-21 promoter regions have binding sites for several transcriptional factors such as AP-1, STAT-3, MyD88, and NF-κB [32] [33] [34] [35] . Aberrant activation of NF-κB has been linked to inflammatory and autoimmune disorders [36] [37] [38] [39] . Given that TGF-β signal negatively regulates NF-κB transcriptional activity [40] [41] [42] , abrogation of TGF-β signaling in dnTGFβRII mice might cause an increase of NF-κB activation, which induced miR-21 overexpression, independent of the global decrease in miRNA that we demonstrate. The combined effect of global decrease in miRNA induced regulation, plus specific upregulation of a subset of deleterious miRNA such as miR21, could thus result in a profound increase in intrinsic T cell mediated immunity. miR21 directly down regulates the expression of PDCD4 that encodes a protein that localizes to the nucleus in proliferating cells. The gene product of PDCD4 plays a role in pathogenic T cell apoptosis and cell proliferation [43] [44] [45] . miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression in human SLE [46] , which suggest that induction of miR-21 may enable T cells to elude activated T cell apoptosis and enhance the potential of pro-inflammatory cytokine secretion, such as IFN-γ and IL-17, by its ability to repress the expression of PDCD4 [47] . miR-21 expression was highest in effector T cells and lowest in naive T cells suggesting that miR-21 may play an important role in maintaining effector phase of the T cells, which is consistent with a previous report [48] . However, the exact pathway linking miR-21 and the increased synthesis of IFN-γ and TNF-α (i.e. whether it is a direct gene effect or a downstream effect of increased cell cycling) remains unknown. There appears to be at least two major ways that mi-R21 can be up-regulated in our dnTGFβRII mice ( Fig. 7) . First, miR 21 up-regulation could be a result of dysregulated gene expression normally controlled by TGFβ (pathway on the right). In this scenario, loss of gene regulation leads to a decreased in SMAD factors (eg SMAD-3) which drives the inflammation leading to activation of pathways such as NFKB and MAPK. The up-regulation of these pathways in turn has been shown to up-regulate mir21 directly. Thus, mir21 up-regulation can, via a positive feedback loop, up-regulate inflammation. In the second pathway (on the left), global down regulation of miR expression (as we demonstrate in figure two) leads to an upregulation of multiple genes causing inflammation; this in turn could lead to the upregulation of miR-21 with feedback up-regulation of inflammation. The two pathways may both be operative. Clarifying which pathway is primary in dnTGFβRII mice will be critical to our understanding of the pathogenesis of autoimmunity. Inflammatory changes in 9-week-old dnTGFβRII mice. A. Representative H&E staining of liver and colon sections. Note the presence of infiltrating lymphoid cells around the portal area, especially surrounding the bile duct. Lymphoid cells were diffuse infiltrating in colon. B. Comparison of proinflammatory cytokine levels in serum, liver and colon between dnTGFβRII mice (n=6) and B6 mice (n=6) at 9 weeks of age. C. Compare cell numbers of intrahepatic MNCs, CD4 + T cells, and CD8 + T cells in dnTGFβRII mice (n=6) with B6 mice (n=6) at 9 weeks of age. D. Analysis of MNC number isolated from the mLN of dnTGFβRII mice (n=7) as well as B6 mice (n=7) at 9 weeks of age. *, P < 0.05; **, P < 0.01; ***, P < 0.001; determined using two-tailed unpaired Mann-Whitney test. Horizontal bars represent standard deviation. miRNAs are predominantly down-regulated in dnTGFβRII splenic CD4 + and CD8 + T cells but miR-21 is upregulated. A. 320 and 285 out of 376 miRNAs in splenic CD4 + and CD8 + T cells, respectively, passed the initial Ct cutoff (see methods). The FC of these miRNAs in dnTGFβRII compared to B6 cells was calculated using the delta delta Ct method and log 2 FC was plotted for each of 320 miRNAs in CD4 + T cells and 285 miRNAs in CD8 + T cells. In CD4 + T cells, 86 miRNA have more than 2-fold decrease in dnTGFβRII CD4 + T cells with miR-300 expressed at the lowest FC, and 28 miRNAs have more than 2-fold increase in dnTGFβRII CD4 + T cells compared to B6 CD4 + T cells. In CD8 + T cells, 142 miRNAs have more than 2-fold decrease in dnTGFβRII CD8 + T cells compared to B6 CD8 + T cells, Relative expression levels of miR-21 in spleen, liver, and colon of dnTGFβRII mice (n=6) and B6 mice (n=6), Horizontal bars represent standard deviation. **, P < 0.01; ***, P < 0.001; determined using two-tailed unpaired Mann-Whitney test. Relative expression of miR-21 in naïve and effector T cells. A. naïve and effector CD4 + and CD8 + T cells were isolated from spleen, liver, and mLN by MoFlo cell sorter. Real-time PCR were performed for miR-21 expression. B. miR-21 expression levels in each organ (liver, spleen, mLN) of dnTGFβRII mice (n=6) were compared. *, P < 0.05, **, P < 0.01, ***, P < 0.001, determined using two-tailed unpaired Mann-Whitney test. Age related miR-21 expression in CD4 + and CD8 + T cells. A. Relative expression of miR-21 in thymic CD4 + and CD8 + T of 2 weeks old dnTGFβRII mice and B6 mice. B. miR-21 expression in splenic CD4 + and CD8 + T cells of 2 and 9 weeks old dnTGFβRII mice was compared with age-matched B6 mice. Transfection of miR-21 mimic into B6 CD4 + and CD8 + T cells. A. CD4 + and CD8 + T cells isolated from spleen of B6 mice were transfected with 25nM miR-21 mimics, negative control siRNA, or with TransIT-TKO reagent only. After overnight transfection, the levels of miR-21 expression were measured by real-time PCR. B. Transfected CD4 + and CD8 + T cells were stimulated with 0.5ng/ml anti-CD3/CD28 for 48 hours, cytokines in supernatant were measured by a mouse Th1/Th2/Th17 CBA kit. *, P < 0.05, **, P < 0.01, ***, P < 0.001, determined using two-tailed unpaired Mann-Whitney test. Proposed model for upregulation of miR-21 in dnTGFβRII T cells.
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